Oral Bioavailability

Low aqueous solubility resulting in poor oral bioavailability of drug candidates is an increasingly 
common challenge for the pharmaceutical industry. An estimated 60% to 70% of compounds in 
early development have poor bioavailability due to low solubility, representing a significant loss in 
economic and therapeutic opportunity. Capsugel Dosage Form Solutions has developed a patented 
delivery platform based on spray-dried dispersions (SDDs), which is available for license.

Download Brochure